KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Work In Process (2016 - 2019)

NovoCure's Work In Process history spans 6 years, with the latest figure at $9.1 million for Q2 2019.

  • For Q2 2019, Work In Process rose 73.08% year-over-year to $9.1 million; the TTM value through Jun 2019 reached $9.1 million, up 73.08%, while the annual FY2018 figure was $8.7 million, 2.75% up from the prior year.
  • Work In Process for Q2 2019 was $9.1 million at NovoCure, up from $8.2 million in the prior quarter.
  • Across five years, Work In Process topped out at $11.0 million in Q2 2017 and bottomed at $3.2 million in Q3 2015.
  • The 5-year median for Work In Process is $8.2 million (2016), against an average of $7.5 million.
  • The largest annual shift saw Work In Process soared 260.78% in 2015 before it tumbled 51.99% in 2018.
  • A 5-year view of Work In Process shows it stood at $4.6 million in 2015, then surged by 79.56% to $8.3 million in 2016, then increased by 1.72% to $8.4 million in 2017, then grew by 2.75% to $8.7 million in 2018, then rose by 5.18% to $9.1 million in 2019.
  • Per Business Quant, the three most recent readings for NVCR's Work In Process are $9.1 million (Q2 2019), $8.2 million (Q1 2019), and $8.7 million (Q4 2018).